Image from Google Jackets

Diseases of the Liver and Biliary Tree / edited by Annarosa Floreani.

Contributor(s): Floreani, Annarosa, editor literario
Material type: materialTypeLabelE-bookPublisher: Cham, Switzerland : Springer International Publishing, 2021Edition: First edition 2021.Description: 1 recurso en línea (VIII, 293 páginas) : 40 ilustraciones, 21 ilustraciones a color.ISBN: 9783030659080.Subject: Hígado -- EnfermedadesOnline resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)Digital Resources
Contents:
Part 1. Congenital biliary abnormalities: Biliary atresia. Congenital cystic lesion of the biliary tree. Biliary hamartomas -- Part 2. Genetic cholangiopathies: Alagille syndrome. Caroli disease. Liver disease in cystic fibrosis. Low-phospholipidic associated cholelithiasis (LPAC syndrome) -- Part 3. Autoimmune cholangiopathies: Primary Biliary Cholangitis. Primary sclerosing cholangitis. IgG4-related cholangitis. Overlap syndromes -- Part 4. Secondary cholangiopathies: Inflammatory cholangitis. Drug-induced cholangiopathies -- Part 5 Neoplasms of the biliary tree:Cholangiocarcinoma -- Part 6. Special topics: Pregnancy and diseases of the biliary tree. Transplant and diseases of the biliary tree.
Abstract: This book provides a comprehensive overview of the diagnosis and management of diseases of the biliary tree. Topics covered include: congenital biliary abnormalities, genetic cholangiopathies, autoimmune cholangiopathies, inflammatory and drug-related cholangiopathies, and cholangiocarcinoma. Given their particular importance (even for clinicians working with adults), pediatric conditions are also examined. In addition, a special section is devoted to pregnancy and diseases of the biliary tree, and to transplants and diseases of the biliary tree. Each chapter offers up-to-date information on the management of the diseases discussed. Moreover, the book addresses new treatments for autoimmune cholestatic liver diseases, reflecting the new therapeutic targets that have recently been discovered. Examples include farnesoid X receptor (FXR) and peroxisome proliferator-activated receptor (PPAR)-agonists, together with new drugs that affect the composition of bile flow. Given its scope, the book offers a valuable guide for a broad range of practitioners.
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Collection Call number Status Date due Barcode Item holds
LIBRO-E NO PRÉSTAMO LIBRO-E NO PRÉSTAMO Madrid Digital Acceso Electrónico (UEM) Ciencias de la Salud RC845 2021 EB (Browse shelf(Opens below)) Acceso electrónico eBook.14032233
Total holds: 0

Part 1. Congenital biliary abnormalities: Biliary atresia. Congenital cystic lesion of the biliary tree. Biliary hamartomas -- Part 2. Genetic cholangiopathies: Alagille syndrome. Caroli disease. Liver disease in cystic fibrosis. Low-phospholipidic associated cholelithiasis (LPAC syndrome) -- Part 3. Autoimmune cholangiopathies: Primary Biliary Cholangitis. Primary sclerosing cholangitis. IgG4-related cholangitis. Overlap syndromes -- Part 4. Secondary cholangiopathies: Inflammatory cholangitis. Drug-induced cholangiopathies -- Part 5 Neoplasms of the biliary tree:Cholangiocarcinoma -- Part 6. Special topics: Pregnancy and diseases of the biliary tree. Transplant and diseases of the biliary tree.

This book provides a comprehensive overview of the diagnosis and management of diseases of the biliary tree. Topics covered include: congenital biliary abnormalities, genetic cholangiopathies, autoimmune cholangiopathies, inflammatory and drug-related cholangiopathies, and cholangiocarcinoma. Given their particular importance (even for clinicians working with adults), pediatric conditions are also examined. In addition, a special section is devoted to pregnancy and diseases of the biliary tree, and to transplants and diseases of the biliary tree. Each chapter offers up-to-date information on the management of the diseases discussed. Moreover, the book addresses new treatments for autoimmune cholestatic liver diseases, reflecting the new therapeutic targets that have recently been discovered. Examples include farnesoid X receptor (FXR) and peroxisome proliferator-activated receptor (PPAR)-agonists, together with new drugs that affect the composition of bile flow. Given its scope, the book offers a valuable guide for a broad range of practitioners.

There are no comments on this title.

to post a comment.